EmbryoTrans Biotech ApS: Financial statements 2020
CVR: 36701676
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
EmbryoTrans Biotech ApS (CVR 36701676) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. That is a decrease of 60.6% compared with the year before. Equity in the 2020 report amounted to DKK 242,326. The solvency ratio was 67.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 520,019
- Profit/Loss
- DKK -10,407
- Equity
- DKK 242,326
- Total Assets
- DKK 358,202
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 520 t. | -10 t. | 242 t. | 2 |
| 2019 | - | 1.3 mio. | 23 t. | 253 t. | 2 |
| 2018 | - | 1.1 mio. | -18 t. | 260 t. | - |
| 2017 | - | 1.8 mio. | 172 t. | 377 t. | - |
| 2016 | - | 1.8 mio. | 132 t. | 455 t. | - |
Official annual report
How creditworthy is EmbryoTrans Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
EmbryoTrans Biotech ApS has published its annual report for 2019. Gross profit came to DKK 1,319,977, and the net result was DKK 23,111.
About EmbryoTrans Biotech ApS
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015. The company has been dissolved on 23 February 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company has 4 employees (2018). In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity in the 2020 report amounted to DKK 242,326.